JP2003277289A5 - - Google Patents

Download PDF

Info

Publication number
JP2003277289A5
JP2003277289A5 JP2002376997A JP2002376997A JP2003277289A5 JP 2003277289 A5 JP2003277289 A5 JP 2003277289A5 JP 2002376997 A JP2002376997 A JP 2002376997A JP 2002376997 A JP2002376997 A JP 2002376997A JP 2003277289 A5 JP2003277289 A5 JP 2003277289A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
same
salt
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002376997A
Other languages
English (en)
Japanese (ja)
Other versions
JP4353697B2 (ja
JP2003277289A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002376997A priority Critical patent/JP4353697B2/ja
Priority claimed from JP2002376997A external-priority patent/JP4353697B2/ja
Publication of JP2003277289A publication Critical patent/JP2003277289A/ja
Publication of JP2003277289A5 publication Critical patent/JP2003277289A5/ja
Application granted granted Critical
Publication of JP4353697B2 publication Critical patent/JP4353697B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002376997A 2001-12-27 2002-12-26 がんの予防・治療剤 Expired - Fee Related JP4353697B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002376997A JP4353697B2 (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001398165 2001-12-27
JP2001-398165 2001-12-27
JP2002376997A JP4353697B2 (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Publications (3)

Publication Number Publication Date
JP2003277289A JP2003277289A (ja) 2003-10-02
JP2003277289A5 true JP2003277289A5 (de) 2006-01-26
JP4353697B2 JP4353697B2 (ja) 2009-10-28

Family

ID=29252843

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002376997A Expired - Fee Related JP4353697B2 (ja) 2001-12-27 2002-12-26 がんの予防・治療剤

Country Status (1)

Country Link
JP (1) JP4353697B2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005060992A1 (en) * 2003-12-24 2005-07-07 The Walter And Eliza Hall Institute Of Medical Research Therapeutic agents and uses therefor

Similar Documents

Publication Publication Date Title
EP1302542A4 (de) Neues, physiologisch aktives peptid und dessen verwendung
IL147271A (en) Isolated peptide ligands that bind to her2
MXPA02011379A (es) Ensayo de deteccion de genes para mejorar la probabilidad de una respuesta efectiva a terapia de cancer con el antagonista erbb.
RU2007136026A (ru) Варианты ил-21
WO2002087507A3 (en) Breast cancer-associated genes and uses thereof
JP7495390B2 (ja) Ｆｇｆｒ１変異陽性脳腫瘍を治療するための医薬組成物及び治療方法
WO2001055178A3 (en) Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
CN101970457A (zh) Iap抑制剂
CN102124004A (zh) Iap的氮杂吲哚抑制剂
WO2004062574A3 (en) Improved linkers for radiopharmaceutical compounds
EA200501197A1 (ru) Композиции и способы для лечения злокачественной опухоли с применением igsf9 и liv - 1
CN111542326A (zh) 转铁蛋白受体(TfR)的RNA适体
JP2003277289A5 (de)
WO2003083102A3 (en) Cancer associated protein phosphatases and their uses
JP2003277288A5 (de)
US7799753B2 (en) Bisubstrate inhibitors of protein tyrosine kinases as therapeutic agents
WO2001057069A3 (en) Targeting peptides
Tanaka et al. Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma
WO2005023186A3 (en) Methods of identifying agents that inhibit the growth of cancer cells
US10610514B2 (en) Composition comprising compound inhibiting interactions of MBD2 and P66α for anti-metastasis and prevention and treatment of cancer disease
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
WO2005112988B1 (en) Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1)
EP1666880A4 (de) Screening-verfahren
JP2002355060A5 (de)
EP1760087A4 (de) Neuer proteinkomplex und anwendungen davon